On March 15, 2022, Talis Biomedical Corporation announced that Douglas Liu will be stepping down as the Company's Chief Operating Officer, effective April 15, 2022. The Company presently does not intend to fill the position of Chief Operating Officer. Instead, upon Mr. Liu's departure, his responsibilities will be transitioned to other parts of the Company's organization, each of which will ultimately report to the Company's Chief Executive Officer.